UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.Read more
Thomas Jefferson University Awarded $508,000 by the Commonwealth to support CoraVax™, a patented COVID-19 vaccineRead more
A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.Read more
The National Institutes of Health will soon launch a phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.Read more
The AIDS Clinical Trials Group (ACTG) has initiated the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple promising investigational agents for treating early COVID-19 in a single trial.Read more
In response to the COVID-19 pandemic, DePaul University has called on its scientific community to address challenges in the areas of disease dynamics, health diagnostics, security, preparation for testing, and clinical care related to the outbreak.Read more
As we continue to grapple with the global pandemic, rising summer temperatures and wildfire season pose new challenges to ourRead more
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.Read more
During the novel coronavirus pandemic, many couples have concerns about reproductive consequences related to COVID-19. Experts say when it comesRead more
Researchers have performed the first room temperature X-ray measurements on the SARS-CoV-2 main protease—the enzyme that enables the virus to reproduce. It marks an important first step in the ultimate goal of building a comprehensive 3D model of the enzymatic protein that will be used to advance supercomputing simulations aimed at finding drug inhibitors to block the virus’s replication mechanism and help end the COVID-19 pandemic.Read more
Cleveland Clinic researchers have developed the world’s first risk prediction model for healthcare providers to forecast an individual patient’s likelihood of testing positive for COVID-19 as well as their outcomes from the disease.
According a new study published in CHEST, the risk prediction model (called a nomogram) shows the relevance of age, race, gender, socioeconomic status, vaccination history and current medications in COVID-19 risk.
Can art help doctors better understand their patients and address racial disparities? An innovative collaboration at the University of Alabama at Birmingham uses art to help medical students hone their observational skills, in order to make more accurate diagnoses. “Prescribing Art: How Observation Enhances Medicine” is a partnership between the School of Medicine, the Abroms-Engel Institute for Visual Arts and the Birmingham Civil Rights Institute.Read more